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Background
Heavy metals used in industrial and household applica-
tions can pose harmful health effects. Tungsten alloys
(WAs) have been widely used in many engineering, auto-
motive and marine applications. In military operations,
WAs containing tungsten (W; 91% w/w), nickel (Ni; 6%
w/w) and cobalt (Co; 3% w/w) have been deployed in
armor-penetrating munitions as substitutes for depleted
uranium. Despite widespread use, a clear understanding of
the potential effects of WAs on physiological processes
and gene expression is not available. WAs have carcino-
genic potential as demonstrated by cancer development in
rats with intramuscular implanted WA pellets. This sug-
gests a potential involvement of epigenetic events pre-
viously implicated as environmental triggers of cancer.
In the present study, we have attempted to unravel WA-
mediated alterations in gene expression and gene-specific
epigenetic modifications at the genome-wide level.
Materials and methods
C2C12 (mouse myoblast) cell cultures were exposed to
1,000 µM WA for 24 h. ChIP assays were performed with
cross-linked cells from WA-treated and untreated C2C12
cultures using anti-RNA Pol II, anti-phospho histone
H3Ser10, anti-trimethyl histone H3K4 and anti-trimethyl
histone H3K27 antibodies. ChIP assays were followed by
sequencing where single-ended 50 bp reads were gener-
ated using a combination of the Applied Biosystems
SOLiD™ and Illumina Hi-Seq™ systems. Data analysis
was done using in-house developed pipelines (PERL/Unix)
as well as several open source bioinformatics software
from R/Bioconductor project and other sources.
Results
Using different in vitro models, we examined metal-
induced cytotoxicity and epigenetic modifications where
WA showed cytotoxicity at concentrations >50 µg/ml,
with C2C12 being relatively resistant to WA-mediated
toxic impact. Using ChIP-Seq, we found several histone
modifications up- and downregulated in the promoter
regions of genes related to learning and memory mechan-
isms, with maximum impact observed for H3Ser10 phos-
phorylation. A total of 101 regions in the mouse genome
were found to be most significantly depleted of H3S10
phosphorylation after WA treatment (fold change >3),
these targets included several genes with neurological
functions including voltage-dependent calcium channel
(CACNB1), phosphatidylinositol 4-kinase type 2 (Pi4k2a)
and Kinesin 5A (KIF5A). In addition, pathway analysis of
these 101 regions revealed 15 genes as part of regulatory
networks that are responsible for developmental disorders,
hereditary disorders and neurological diseases. ChIP-Seq
analysis of other histone modifications and Pol II binding
patterns are still ongoing. We plan to correlate expression
levels investigated by RNA-Seq and epigenetic profiles
impacted by WA exposure.
Conclusions
Our results reveal epigenetic modifications triggered by
WA exposure in C2C12 cells for the first time at a gen-
ome-wide level. In addition to epigenetic changes observed
for specific genes, ChIP-Seq analysis confirmed our pre-
vious report on the gross genomic depletion of H3Ser10
phosphorylation [1]. Future investigations on genes identi-
fied in this study will help unravel the mechanisms
involved in WA toxicity that may lead towards the devel-
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